Sinclair Dermatology

Melbourne, Victoria 3995

1 studies enrolling now · 5 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Hidradenitis Suppurativa

Studies at this site

• A Study of Zasocitinib in Adults With Hidradenitis Suppurativa — Recruiting now
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis — NO_LONGER_AVAILABLE
• A Phase II Study in Patients With Alopecia Areata — Completed